Used as a key chiral intermediate in the synthesis of pharmaceuticals, particularly in the development of protease inhibitors and antiviral agents. Its stereochemistry enables selective interactions in biological systems, making it valuable in creating drugs with high specificity and reduced side effects. Commonly employed in the preparation of active pharmaceutical ingredients (APIs) where fluorinated pyrrolidine structures enhance metabolic stability and bioavailability. Also utilized in medicinal chemistry research for structure-activity relationship (SAR) studies involving peptidomimetics and enzyme inhibitors.